کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6005064 1184365 2012 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson's disease: Results from a 1-year, open-label extension of the RECOVER study
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
پیش نمایش صفحه اول مقاله
Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson's disease: Results from a 1-year, open-label extension of the RECOVER study
چکیده انگلیسی
► Rotigotine is a non-ergoline dopamine agonist with activity across D1-D5 receptors. ► Rotigotine is administered once-daily via a transdermal patch for treatment of PD. ► A 1-year open label extension study of RECOVER, the rotigotine Phase IIIb trial. ► Adverse events were mild or moderate in intensity and resolved by trial end. ► Rotigotine had beneficial effects on motor function and sleep for up to 1 year.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Basal Ganglia - Volume 2, Issue 2, July 2012, Pages 79-85
نویسندگان
, , , , , , , ,